Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit
The original release is unavailable here.
Earlier from Whitehawk Therapeutics
- Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
- Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing
- Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
- Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026